Regulation of androgen receptor-mediated transcription by RPB5 binding protein URI/RMP

Molecular and Cellular Biology

Volumn 31, Issue 17, 2011, Pages 3639-3652

  Mita, Paolo ^a   Savas, Jeffrey N ^b   Djouder, Nabil ^d   Yates, John R ^b   Ha, Susan ^a   Ruoff, Rachel ^a   Schafler, Eric D ^a   Nwachukwu, Jerome C ^c   Tanese, Naoko ^a   Cowan, Nicholas J ^a   Zavadil, Jiri ^a   Garabedian, Michael J ^a   Logan, Susan K ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c SCRIPPS RESEARCH INSTITUTE   (United States)

^d BBVA University Institute for Economic and Social Analysis University of Alcalá   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; ANDROGEN RECEPTOR TRAPPED CLONE 27; BICALUTAMIDE; BINDING PROTEIN; COREPRESSOR PROTEIN; UNCLASSIFIED DRUG; UNCONVENTIONAL PREFOLDIN RPB5 INTERACTOR;

ANDROGEN THERAPY; ARTICLE; CANCER GROWTH; CHROMATIN; EMBRYO; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE OVEREXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN INTERACTION; PROTEIN PHOSPHORYLATION; TRANSCRIPTION INITIATION; TRANSCRIPTION REGULATION;

ANDROGEN ANTAGONISTS; ANILIDES; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN; CHROMATIN IMMUNOPRECIPITATION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; METRIBOLONE; NEOPLASM PROTEINS; NITRILES; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHOSPHORYLATION; PROSTATIC NEOPLASMS; PROTEIN BINDING; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TOSYL COMPOUNDS; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 80052330956     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.05429-11     Document Type: Article

References (33)

1. Boulon, S., et al. 2010. HSP90 and its R2TP/Prefoldin-like cochaperone are involved in the cytoplasmic assembly of RNA polymerase II. Mol. Cell 39:912-924.
2. Chen, C. D., et al. 2004. Molecular determinants of resistance to antiandrogen therapy. Nat. Med. 10:33-39.
3. Cloutier, P., et al. 2009. High-resolution mapping of the protein interaction network for the human transcription machinery and affinity purification of RNA polymerase II-associated complexes. Methods 48:381-386.
4. Cloutier, P., and B. Coulombe. 2010. New insights into the biogenesis of nuclear RNA polymerases? Biochem. Cell Biol. 88:211-221.
5. Delgermaa, L., et al. 2004. Subcellular localization of RPB5-mediating protein and its putative functional partner. Mol. Cell. Biol. 24:8556-8566.
6. Deplazes, A., N. Mockli, B. Luke, D. Auerbach, and M. Peter. 2009. Yeast Uri1p promotes translation initiation and may provide a link to cotranslational quality control. EMBO J. 28:1429-1441.
7. Djouder, N., et al. 2007. S6K1-mediated disassembly of mitochondrial URI/PP1γ complexes activates a negative feedback program that counters S6K1 survival signaling. Mol. Cell 28:28-40.
8. Dorjsuren, D., et al. 1998. RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein. Mol. Cell. Biol. 18:7546-7555.
9. Feldman, B. J., and D. Feldman. 2001. The development of androgenindependent prostate cancer. Nat. Rev. Cancer 1:34-45.
10. Freeman, B. C., S. J. Felts, D. O. Toft, and K. R. Yamamoto. 2000. The p23 molecular chaperones act at a late step in intracellular receptor action to differentially affect ligand efficacies. Genes Dev. 14:422-434.
11. Gstaiger, M., et al. 2003. Control of nutrient-sensitive transcription programs by the unconventional prefoldin URI. Science 302:1208-1212.
12. Guicciardi, M. E., and G. J. Gores. 2008. Cell stress gives a red light to the mitochondrial cell death pathway. Sci. Signal. 1:pe9.
13. Jeronimo, C., et al. 2007. Systematic analysis of the protein interaction network for the human transcription machinery reveals the identity of the 7SK capping enzyme. Mol. Cell 27:262-274.
14. Kirchner, J., et al. 2008. Drosophila Uri, a PP1_ binding protein, is essential for viability, maintenance of DNA integrity and normal transcriptional activity. BMC Mol. Biol. 9:36.
15. Le, T. T., et al. 2005. Mutational analysis of human RNA polymerase II subunit 5 (RPB5): the residues critical for interactions with TFIIF subunit RAP30 and hepatitis B virus X protein. J. Biochem. 138:215-224.
16. Markus, S. M., et al. 2002. Identification and characterization of ART-27, a novel coactivator for the androgen receptor N terminus. Mol. Biol. Cell 13:670-682.
17. Mellinghoff, I. K., and C. L. Sawyers. 2004. TORward AKTually useful mouse models. Nat. Med. 10:579-580.
18. Nwachukwu, J. C., et al. 2009. Genome-wide impact of androgen receptor trapped clone-27 loss on androgen-regulated transcription in prostate cancer cells. Cancer Res. 69:3140-3147.
19. Oxelmark, E., et al. 2006. The cochaperone p23 differentially regulates estrogen receptor target genes and promotes tumor cell adhesion and invasion. Mol. Cell. Biol. 26:5205-5213.
20. Parusel, C. T., E. A. Kritikou, M. O. Hengartner, W. Krek, and M. Gotta. 2006. URI-1 is required for DNA stability in C. elegans. Development 133: 621-629.
21. Rai, J. S., M. J. Henley, and H. L. Ratan. 2010. Mammalian target of rapamycin: a new target in prostate cancer. Urol. Oncol. 28:134-138.
22. Shang, Y., M. Myers, and M. Brown. 2002. Formation of the androgen receptor transcription complex. Mol. Cell 9:601-610.
23. Taneja, S. S., et al. 2004. ART-27, an androgen receptor coactivator regulated in prostate development and cancer. J. Biol. Chem. 279:13944-13952.
24. Taylor, B. S., et al. 2010. Integrative genomic profiling of human prostate cancer. Cancer Cell 18:11-22.
25. Thomas, M. A., D. M. Preece, and J. M. Bentel. 2010. Androgen regulation of the prostatic tumour suppressor NKX3.1 is mediated by its 3' untranslated region. Biochem. J. 425:575-583.
26. Tomlins, S. A., et al. 2007. Integrative molecular concept modeling of prostate cancer progression. Nat. Genet. 39:41-51.
27. Tomlins, S. A., et al. 2005. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science 310:644-648.
28. Tronnersjo, S., et al. 2007. The jmjN and jmjC domains of the yeast zinc finger protein Gis1 interact with 19 proteins involved in transcription, sumoylation and DNA repair. Mol. Genet. Genomics 277:57-70.
29. Vainberg, I. E., et al. 1998. Prefoldin, a chaperone that delivers unfolded proteins to cytosolic chaperonin. Cell 93:863-873.
30. Wei, W., et al. 2003. Interaction with general transcription factor IIF (TFIIF) is required for the suppression of activated transcription by RPB5-mediating protein (RMP). Cell Res. 13:111-120.
31. Wysocka, J., P. T. Reilly, and W. Herr. 2001. Loss of HCF-1-chromatin association precedes temperature-induced growth arrest of tsBN67 cells. Mol. Cell. Biol. 21:3820-3829.
32. Xu, Y., S. Y. Chen, K. N. Ross, and S. P. Balk. 2006. Androgens induce prostate cancer cell proliferation through mammalian target of rapamycin activation and posttranscriptional increases in cyclin D proteins. Cancer Res. 66:7783-7792.
33. Yart, A., et al. 2005. The HRPT2 tumor suppressor gene product parafibromin associates with human PAF1 and RNA polymerase II. Mol. Cell. Biol. 25:5052-5060.